Varian Medical Systems, the world’s leading manufacturer of medical devices and software for treating and managing cancer, is introducing an entirely new device for cancer treatment called Halcyon™, the system designed to expand the availability of high-quality cancer care globally and help save the lives of millions more cancer patients.
According to Kolleen Kennedy, president of Varian’s Oncology Systems business. “It is expected that there will be 24.6 million cancer cases diagnosed annually by 2030, and there is an acute shortage of equipment and trained clinicians. With the innovations in this new technology platform, the system will deliver high-quality Halcyon treatments that empower clinicians to care for many more patients. At Varian, we are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide.”